Search results
GSK profit drops in first quarter on higher costs
Digital Journal· 6 days agoBritish drugmaker GlaxoSmithKline on Wednesday said its net profit fell 23 percent in the first quarter as the company faced higher exceptional costs...
Sen. Hassan slams GlaxoSmithKline over cost of asthma inhalers
New Hampshire Union Leader· 5 days agoPharmaceutical giant GlaxoSmithKline is sidestepping its pledge to lower asthma inhaler prices, a...
FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic
CNBC· 6 days agoThe Federal Trade Commission on Tuesday said it is challenging hundreds of alleged "junk" patents...
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition - KVIA
ABC 7 El Paso· 7 days agoBy MATTHEW PERRONE AP Health Writer WASHINGTON (AP) — The Federal Trade Commission is challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic. Tuesday ...
FTC challenges ‘bogus’ patents on Ozempic, other drugs that ‘block competition’
Market Watch· 7 days agoFederal regulators are challenging patents on 20 brand-name drugs, including the blockbuster...
Janssen adopts J&J name as part of global rebranding effort
Pharmaceutical Technology via Yahoo Finance· 6 days agoOver the past 100 years, our first responsibility has always been to the patients...unveiled a new...
5 best blue chip stocks to invest in for sustainable gains in May - excluding Apple Inc. (AAPL) |...
Invezz· 4 days agoYesterday, the biggest company in the world in terms of market cap reported its latest earnings....
Superbug Slayer: New Class of Antibiotics Proves Potent Against Multi-Drug Resistant Bacteria
SciTechDaily· 7 days agoA new class of antibiotics capable of combating multi-drug resistant bacteria and treating bloodstream infections in mice has been unveiled by Uppsala University scientists. Scientists at Uppsala ...